Potential method to determine irritant potency in vitro - Comparison of two reconstructed epidermal culture models with different barrier competency.
Testing chemicals for their ability to cause skin irritation is required for all ingredients of products that come into contact with the skin. Here, we describe a potential method for determining the irritant potency of a chemical in vitro and apply the method to two different reconstructed epidermis models which exhibit different barrier properties. Two surfactants: sodium dodecyl sulphate, Triton X100 and two non-surfactants: 2-4-di-nitro-chloro-benzene, cinnamaldehyde were applied topically in a dose response for 24h. Biomarkers IL-1alpha, IL-1RA, IL-8 and MTT were assessed and EC(50) values determined. Variation in barrier properties between the epidermal models led to variation in the extent of penetration of surfactants, but not of non-surfactants which in turn influenced the EC(50) value obtained from surfactants. Furthermore, EC(50) values showed that no single biomarker could be classed as the most sensitive biomarker since biomarker sensitivity differed between the different chemicals studied. However, the ranking of the chemicals in order of strong to weak irritant was the same irrespective of the model used and also independent of the biomarker used (Triton X100>DNCB>SDS>CA). This study describes a method which not only distinguishes an irritant from a non-irritant but which may possibly also be used to determine irritant potency.
Spiekstra
S W
SW
Departments of Dermatology, VU University Medical Centre, Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
Dos Santos
G G
GG
Scheper
R J
RJ
Gibbs
S
S
D000171:Acrolein / Q000031:analogs & derivatives / Q000633:toxicity; D015415:Biomarkers / Q000378:metabolism; D002470:Cell Survival / Q000187:drug effects; D016207:Cytokines / Q000378:metabolism; D004137:Dinitrochlorobenzene / Q000633:toxicity; D004305:Dose-Response Relationship, Drug; D004817:Epidermis / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D005562:Formazans / Q000378:metabolism; D006801:Humans; D007231:Infant, Newborn; D007509:Irritants / Q000145:classification / Q000633:toxicity*; D008297:Male; D008954:Models, Biological; D017830:Octoxynol / Q000633:toxicity; D009924:Organ Culture Techniques; D023422:Skin Irritancy Tests; D012882:Skin Tests / Q000379:methods; D012967:Sodium Dodecyl Sulfate / Q000633:toxicity; D013501:Surface-Active Agents / Q000633:toxicity; D013778:Tetrazolium Salts / Q000378:metabolism
D015415:Biomarkers; D016207:Cytokines; D004137:Dinitrochlorobenzene; D005562:Formazans; D007509:Irritants; D013501:Surface-Active Agents; D013778:Tetrazolium Salts; C079782:MTT formazan; D012967:Sodium Dodecyl Sulfate; D000171:Acrolein; D017830:Octoxynol; C012843:cinnamaldehyde